Inventor
BYUN DANIEL
US13 patents
⚠️ This page may combine multiple inventors who share the name “BYUN DANIEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THERAVANCE RESPIRATORY CO LLC
9 patentsUS9394275B2Jul 19, 2016
Diamide compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC7 citations92
US9975875B2May 22, 2018
Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC4 citations84
US9771350B2Sep 26, 2017
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC4 citations84
US9682957B2Jun 20, 2017
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC5 citations84
US9572802B2Feb 21, 2017
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC5 citations84
US10138220B1Nov 27, 2018
Diamide compounds having muscarinic receptor antagonis and beta2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC1 citations62
US10836744B2Nov 17, 2020
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC0 citations51
US10590107B2Mar 17, 2020
Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC0 citations51
US10358433B2Jul 23, 2019
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC0 citations51